e-learning
resources
Munich 2014
Monday, 08.09.2014
Epidemiology, pathogenesis and quality management of thoracic tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer
M. L. Vold, P. C. Moe, E. Ytterstad, A. Hjalmarsen (Tromso, Norway)
Source:
International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Session:
Epidemiology, pathogenesis and quality management of thoracic tumours
Session type:
Thematic Poster Session
Number:
2753
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. L. Vold, P. C. Moe, E. Ytterstad, A. Hjalmarsen (Tromso, Norway). Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer. Eur Respir J 2014; 44: Suppl. 58, 2753
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Incidence of lung cancer in smokers with and without COPD: Observational study
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Improving NLST criteria for lung cancer screening
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment?
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Confirmed pulmonary tuberculosis leading to late diagnosis of lung cancer - Study case
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Lung diseases infection and risk of lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Lung cancer in COPD patients on home oxygen-therapy
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Relationship between lung cancer and chronic obstructive pulmonary disease
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Chronic obstructive pulmonary disease as a predictor of lung cancer mortality
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Lung volume reduction effect after lobectomy in COPD patients
Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Year: 2013
Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Evaluation of incidental lung cancer in hospitalized patients with non-respiratory disease
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy
Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training
Year: 2014
Age related influence of COPD on postoperative pulmonary morbidity in lung cancer patients
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept